Welcome to our Corporate client solution
Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
A new Swedish product for post surgical scar formation enters clinical development.
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.